Literature DB >> 18704881

Targeting epigenetic mechanisms: potential of natural products in cancer chemoprevention.

Alexander-Thomas Hauser1, Manfred Jung.   

Abstract

The term epigenetics is defined as heritable changes in gene expression patterns that occur without changes in DNA sequence. Epigenetic changes according to this definition are achieved by methylation of cytosine bases in the DNA and by histone modifications, such as acetylation, methylation or phosphorylation. These modifications play an important role in regulating gene expression and the existence of an epigenetic code which maintains these modifications even upon cell division has been underlined by many investigations. Targeting the enzymes which catalyze DNA methylation or histone modifications may be a possibility not only for cancer therapy but also for chemoprevention since disruption of epigenetic balance is known to cause diseases such as cancer. In this review, we want to present the key epigenetic targets. We highlight natural products that modulate these epigenetic mechanisms and show their potential for cancer chemoprevention.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18704881     DOI: 10.1055/s-2008-1081347

Source DB:  PubMed          Journal:  Planta Med        ISSN: 0032-0943            Impact factor:   3.352


  11 in total

1.  Sulforaphane enhances Nrf2 expression in prostate cancer TRAMP C1 cells through epigenetic regulation.

Authors:  Chengyue Zhang; Zheng-Yuan Su; Tin Oo Khor; Limin Shu; Ah-Ng Tony Kong
Journal:  Biochem Pharmacol       Date:  2013-02-14       Impact factor: 5.858

2.  Natural products as DNA methyltransferase inhibitors: a computer-aided discovery approach.

Authors:  Jose L Medina-Franco; Fabian López-Vallejo; Dirk Kuck; Frank Lyko
Journal:  Mol Divers       Date:  2010-08-10       Impact factor: 2.943

3.  Hyperactivated NF-{kappa}B and AP-1 transcription factors promote highly accessible chromatin and constitutive transcription across the interleukin-6 gene promoter in metastatic breast cancer cells.

Authors:  'Matladi N Ndlovu; Carine Van Lint; Karlien Van Wesemael; Pieter Callebert; Dany Chalbos; Guy Haegeman; Wim Vanden Berghe
Journal:  Mol Cell Biol       Date:  2009-08-17       Impact factor: 4.272

Review 4.  Dietary phytochemicals as epigenetic modifiers in cancer: Promise and challenges.

Authors:  Eswar Shankar; Rajnee Kanwal; Mario Candamo; Sanjay Gupta
Journal:  Semin Cancer Biol       Date:  2016-04-23       Impact factor: 15.707

5.  From inflammaging to healthy aging by dietary lifestyle choices: is epigenetics the key to personalized nutrition?

Authors:  Katarzyna Szarc vel Szic; Ken Declerck; Melita Vidaković; Wim Vanden Berghe
Journal:  Clin Epigenetics       Date:  2015-03-25       Impact factor: 6.551

Review 6.  Molecular modeling of inhibitors of human DNA methyltransferase with a crystal structure: discovery of a novel DNMT1 inhibitor.

Authors:  Jakyung Yoo; Joo Hee Kim; Keith D Robertson; José L Medina-Franco
Journal:  Adv Protein Chem Struct Biol       Date:  2012       Impact factor: 3.507

7.  Maternal undernutrition and cardiometabolic disease: a Latin American perspective.

Authors:  Patricio Lopez-Jaramillo; Diego Gomez-Arbelaez; Aristides Sotomayor-Rubio; Daniel Mantilla-Garcia; Jose Lopez-Lopez
Journal:  BMC Med       Date:  2015-03-02       Impact factor: 8.775

Review 8.  Research Progress on Chemical Constituents and Anticancer Pharmacological Activities of Euphorbia lunulata Bunge.

Authors:  Yuwei Wang; Xiao Yu; Lingna Wang; Fang Zhang; Yongqing Zhang
Journal:  Biomed Res Int       Date:  2020-01-14       Impact factor: 3.411

9.  Trimethylaurintricarboxylic acid inhibits human DNA methyltransferase 1: insights from enzymatic and molecular modeling studies.

Authors:  Jakyung Yoo; José L Medina-Franco
Journal:  J Mol Model       Date:  2011-07-30       Impact factor: 1.810

Review 10.  Cancer chemoprevention: a rapidly evolving field.

Authors:  W P Steward; K Brown
Journal:  Br J Cancer       Date:  2013-06-04       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.